A study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene ...

The experimental mRNA-based drug sharply reduced the risk of recurrence or death when combined with immunotherapy Keytruda, ...

New research reveals that certain brain tumors may originate silently within normal brain cells long before a tumor forms.

Scientists at Duke-NUS Medical School and the National University Health System (NUHS), together with an international team ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...

Scientists at Leuven University (KU Leuven) and Leuven University Hospital’s (UZ Leuven) Centre for Human Genetics (CME) have ...

Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...

The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.

Hereditary breast cancer results from inherited mutations, primarily in BRCA1 and BRCA2, increasing lifetime cancer risk. Additional genes like TP53, PTEN, PALB2, CHEK2, and ATM also contribute to ...

Duke-NUS and NUHS scientists uncover a complex web of genetic, age-related and microbial factors that increase the risk of stomach cancer. Age-related blood cell mutations may trigger early changes in ...